Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/2/23 21:21 | 10/31/23 | EIGR | Health | BioPrd | Biological Products, (No Diag | Kayne Richard A | CA | T | P.m | 73 | 0.2617 | 0 | 278 | 5 | 5,375 | I | |||||||||||||||
11/2/23 21:14 | 10/31/23 | EIGR | Health | BioPrd | Biological Products, (No Diag | Kawas Leen | CA | T | P | 6 | 0.2620 | 0 | 24 | 1 | 4,391 | I | |||||||||||||||
1/25/23 20:54 | 1/23/23 | EIGR | Health | BioPrd | Biological Products, (No Diag | Dietz Thomas John | CA | D | P | 72 | 1.43 | 0 | 50 | 238 | 71 | I | |||||||||||||||
12/27/22 17:31 | 12/22/22 | EIGR | Health | BioPrd | Biological Products, (No Diag | Glenn Jeffrey S | CA | D | P | 128 | 1.28 | 0 | 100 | 42 | 339 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |